LYEL
Price
$0.47
Change
-$0.04 (-7.84%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
149.83M
40 days until earnings call
RCKT
Price
$5.55
Change
-$0.75 (-11.90%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
591.79M
39 days until earnings call
Ad is loading...

LYEL vs RCKT

Header iconLYEL vs RCKT Comparison
Open Charts LYEL vs RCKTBanner chart's image
Lyell Immunopharma
Price$0.47
Change-$0.04 (-7.84%)
Volume$10.64K
Capitalization149.83M
Rocket Pharmaceuticals
Price$5.55
Change-$0.75 (-11.90%)
Volume$62.39K
Capitalization591.79M
LYEL vs RCKT Comparison Chart
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. RCKT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Hold and RCKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (LYEL: $0.51 vs. RCKT: $6.30)
Brand notoriety: LYEL and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 43% vs. RCKT: 258%
Market capitalization -- LYEL: $137.67M vs. RCKT: $591.79M
LYEL [@Biotechnology] is valued at $137.67M. RCKT’s [@Biotechnology] market capitalization is $591.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, RCKT is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 5 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • LYEL’s TA Score: 5 bullish, 5 bearish.
  • RCKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both LYEL and RCKT are a good buy in the short-term.

Price Growth

LYEL (@Biotechnology) experienced а -3.37% price change this week, while RCKT (@Biotechnology) price change was -18.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

LYEL is expected to report earnings on May 13, 2025.

RCKT is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($592M) has a higher market cap than LYEL($150M). LYEL YTD gains are higher at: -20.703 vs. RCKT (-49.881). LYEL has higher annual earnings (EBITDA): -200.64M vs. RCKT (-247.48M). RCKT (372M) and LYEL (371M) have equal amount of cash in the bank . RCKT has less debt than LYEL: RCKT (25.5M) vs LYEL (59M). LYEL has higher revenues than RCKT: LYEL (61K) vs RCKT (0).
LYELRCKTLYEL / RCKT
Capitalization150M592M25%
EBITDA-200.64M-247.48M81%
Gain YTD-20.703-49.88142%
P/E RatioN/AN/A-
Revenue61K0-
Total Cash371M372M100%
Total Debt59M25.5M231%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELRCKT
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 28 days ago
83%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BKRDX8.130.04
+0.49%
iShares Developed Real Estate Idx K
VENAX65.15N/A
N/A
Vanguard Energy Index Admiral
DLRHX22.89N/A
N/A
Macquarie Healthcare R
OSCCX18.77N/A
N/A
Invesco Main Street Small Cap C
GEORX5.67N/A
N/A
Pear Tree Essex Environmental Opps R6

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
+4.79%
VCYT - LYEL
46%
Loosely correlated
+1.93%
PRME - LYEL
43%
Loosely correlated
+0.28%
RCKT - LYEL
42%
Loosely correlated
+8.43%
NTLA - LYEL
41%
Loosely correlated
+9.69%
CRBU - LYEL
40%
Loosely correlated
+2.37%
More